How High Can Marijuana Stocks Get on Biden Presidency?

There will likely be plenty of opportunities to capitalize on volatility in both directions in the weeks and months to come...

Commodities 1

Three months ago, we identified marijuana stocks as potential winners under a Biden presidency, noting that, “[r]elative to some of the more liberal Democratic candidates, Biden is seemingly lukewarm toward recreational marijuana, but the prospects of full legalization are nonetheless better under Biden than Trump, especially if the House of Representatives and/or Senate is also under Democratic control. In that case, stocks like Canopy Growth (CGC), GW Pharmaceuticals (GWPH), Curaleaf (CURL), Cronos Group (CRON), and Aurora Cannabis (ACB) could catch a bid…”

While not necessarily unique or profound, this perspective has aged well. At one point on Monday, the “Alternative Harvest” ETF (ticker MJ) had surged 33% in less than a week from its pre-election price, and the industry bellwether is still trading up by about 13% from its November 3rd close:

Source: TradingView, GAIN Capital

From a technical perspective, MJ has seen its 21-day EMA cross above its 50-day EMA, signaling a possible shift to a medium-term uptrend (though we did see a similar bullish crossover sputter out back in Q2). The RSI likewise reached “overbought” territory above 70 for the first time since June at the start of the week, a bullish sign from a medium-term perspective.

Drilling down into the top holdings, Canopy Growth (CGC), Tilray (TLRY), Cronos Group (CRON), and Aurora Cannabis (ACB) all saw similar bullish spikes late last week before pulling back so far this week. Moving forward, bullish-inclined traders may want to consider buy entries near the confluence of moving averages if prices continue to pull back, with Aurora Cannabis (ACB) showing notably higher volatility than the other top holdings and therefore offering potentially higher risk and reward for traders comfortable bearing that risk.

Source: TradingView, GAIN Capital

At the risk of being a buzzkill (pun intended), there’s a risk that these marijuana stocks have gotten ahead of themselves. Though the prospects of federal legalization in the United States are certainly rosier under a Biden Presidency than they would have been under Trump, it’s notable that Democrats will likely not have a majority in the US Senate (pending the results of two runoff Senate elections in traditionally red Georgia), so it may be difficult for Democrats to enact their full agenda. And, even if federal legalization is passed in the coming years, there remains a risk of a “buy the rumor, sell the news” reaction in marijuana stocks.

Unlike the lethargy that its ultimate product produces in users, this nascent industry is surrounded by giddy excitement on the part of investors, so there will likely be plenty of opportunities to capitalize on volatility in both directions in the weeks and months to come, regardless of how the federal legal battle shakes out.


More from Equities

Disclaimer: The information on this web site is not targeted at the general public of any particular country. It is not intended for distribution to residents in any country where such distribution or use would contravene any local law or regulatory requirement. The information and opinions in this report are for general information use only and are not intended as an offer or solicitation with respect to the purchase or sale of any currency or CFD contract. All opinions and information contained in this report are subject to change without notice. This report has been prepared without regard to the specific investment objectives, financial situation and needs of any particular recipient. Any references to historical price movements or levels is informational based on our analysis and we do not represent or warranty that any such movements or levels are likely to reoccur in the future. While the information contained herein was obtained from sources believed to be reliable, author does not guarantee its accuracy or completeness, nor does author assume any liability for any direct, indirect or consequential loss that may result from the reliance by any person upon any such information or opinions.

Futures, Options on Futures, Foreign Exchange and other leveraged products involves significant risk of loss and is not suitable for all investors. Losses can exceed your deposits. Increasing leverage increases risk. Spot Gold and Silver contracts are not subject to regulation under the U.S. Commodity Exchange Act. Contracts for Difference (CFDs) are not available for US residents. Before deciding to trade forex and commodity futures, you should carefully consider your financial objectives, level of experience and risk appetite. Any opinions, news, research, analyses, prices or other information contained herein is intended as general information about the subject matter covered and is provided with the understanding that we do not provide any investment, legal, or tax advice. You should consult with appropriate counsel or other advisors on all investment, legal, or tax matters. References to Forex.com or GAIN Capital refer to GAIN Capital Holdings Inc. and its subsidiaries. Please read Characteristics and Risks of Standardized Options.